Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 504-509

  Bertolini, Francesco ^a   Paolucci, Mara ^a   Peccatori, Fedro ^a   Cinieri, Saverio ^a   Agazzi, Alberto ^a   Ferrucci, Pier Francesco ^a   Cocorocchio, Emilia ^a   Goldhirsch, Aron ^a   Martinelli, Giovanni ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Angiogenesis; Angiogenic growth factors; Endostatin; Non Hodgkin's lymphoma

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENDOSTATIN; LEPTIN; PREDNISONE; VASCULOTROPIN; VINCRISTINE SULFATE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; ANTINEOPLASTIC AGENTS; COLLAGEN; ENDOSTATINS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOKINES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROGNOSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032845702     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01547.x     Document Type: Article

References (19)

1. Banks, R.E., Forbes, M.A., Kinsey, S.E., Stanley, A., Ingham, E., Walters, C. & Selby, P.J. (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance of VEGF measurements and cancer biology. British Journal of Cancer, 77, 956-964.
2. Bohem, T., Folkman, J., Browder, T. & O'Reilly, M.S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 390, 404-407.
3. Dirix, L.Y., Vermeulen, P.B., Pawinski, A., Prove, A., Benoy, I., De Pooter, C., Martin, M. & van Oosterom, A.T. (1997) Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. British Journal of Cancer, 76, 238-243.
4. Fernandez-Acenero, M.J., Gonzalez, J.F., Galindo Gallego, M. & Aragoncillo Ballestreros, P. (1998) Vascular enumeration as a significant prognosficator for invasive breast carcinoma. Journal of Clinical Oncology, 16, 1684-1688.
5. Ferrara, N. & Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocrine Reviews, 18, 4-25.
6. Fiedler, W., Graeven, U., Ergun, S., Verago, S., Kilic, N., Stockschlader, M. & Hossfeld, D.K. (1997) Vascular endothelial growth factor, a possible paracrine factor in human acute myeloid leukemia. Blood, 89, 1870-1875.
7. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1, 27-31.
8. Foss, H.D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M. & Stein, H. (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology, 183, 44-50.
9. Graham, C., Rivers, J., Kerbel, R., Stankiewicz, K. & White, W. (1994) Extent of neovascularization as a prognostic indicator in thin (<0·76 mm) melanomas. American Journal of Pathology, 145, 510-514.
10. Linderholm, B., Tavelin, B., Grankvist, K. & Henriksson, R. (1998) Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. Journal of Clinical Oncology, 16, 3121-3128.
11. Mohle, R., Green, D., Moore, M.A., Nachman, R.L. & Rafii, S. (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proceedings of the National Academy of Sciences of the United States of America, 94, 663-668.
12. Nguyen, M., Watanabe, H., Budson, A.E., Richie, J.P., Hayes, D.F. & Folkman, J. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. Journal of the National Cancer Institute, 86, 356-361.
13. Olson, K.A., Verselis, S.J. & Fett, J.W. (1998) Angiogenin is regulated in vivo as an acute phase protein. Biochemical and Biophysical Research Communications, 242, 480-483.
14. O'Reilly, M.S., Bohem, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R. & Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumour growth. Cell, 88, 277-285.
15. Perez-Atayde, A.R., Sallan, S.E., Tedrow, U., Connors, S., Allred, F., & Folkman, J. (1997) Spectrum of tumour angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. American Journal of Pathology, 150, 815-821.
16. Salven, P., Lymboussaki, A., Hekkila, P., Jaaskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K. & Joensuu, H. (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. American Journal of Pathology 153, 103-108.
17. Salven, P., Teerenhovi, L. & Joensuu, H. (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood, 90, 3167-3172.
18. Sierra-Honigmann, M.R., Nath, A.K., Murakami, C., Garcia-Cardena, G., Papapetropolous, A., Sessa, W.C., Madge, L.A., Schechner, J.S., Schwabb, M.B., Ploverini, P.J. & Flores-Riveros, J.R. (1998) Biological action of leptin as an angiogenic factor. Science, 281, 1683-1686.
19. Weidner, N., Semple, J.P., Welch, W.R. & Folkman, J. (1991) Tumor angiogenesis and metastasis: correlation with invasive breast carcinoma. New England Journal of Medicine, 324, 1-8.